Valerie Foy, Daniel L Fischer, Nicole Tilin, Graham Litchman, Adam J Friedman
{"title":"眼部皮肤病的药理并发症:综述与最新进展。","authors":"Valerie Foy, Daniel L Fischer, Nicole Tilin, Graham Litchman, Adam J Friedman","doi":"10.36849/jdd.8236","DOIUrl":null,"url":null,"abstract":"<p><p>Many dermatologic medications have the potential to induce ocular complications. Traditional medications, including corticosteroids, retinoids, antibiotics, antihistamines, and immunosuppressants, have been associated with eye dryness, irritation, allergy, infection, atrophy, pigmentary changes, increased intraocular pressure, and impaired vision. Novel therapeutic agents such as biologics raise new concerns for ocular surface disease and conjunctivitis. Dermatologists should recognize these oculocutaneous side effects for appropriate decision-making, coordinating interdisciplinary care, and optimizing patient outcomes. J Drugs Dermatol. 2024;23(12):1108-1113. doi:10.36849/JDD.8236.</p>","PeriodicalId":15566,"journal":{"name":"Journal of Drugs in Dermatology","volume":"23 12","pages":"1108-1113"},"PeriodicalIF":1.5000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pharmacological Complications in Ocular Dermatology: A Review and Update.\",\"authors\":\"Valerie Foy, Daniel L Fischer, Nicole Tilin, Graham Litchman, Adam J Friedman\",\"doi\":\"10.36849/jdd.8236\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Many dermatologic medications have the potential to induce ocular complications. Traditional medications, including corticosteroids, retinoids, antibiotics, antihistamines, and immunosuppressants, have been associated with eye dryness, irritation, allergy, infection, atrophy, pigmentary changes, increased intraocular pressure, and impaired vision. Novel therapeutic agents such as biologics raise new concerns for ocular surface disease and conjunctivitis. Dermatologists should recognize these oculocutaneous side effects for appropriate decision-making, coordinating interdisciplinary care, and optimizing patient outcomes. J Drugs Dermatol. 2024;23(12):1108-1113. doi:10.36849/JDD.8236.</p>\",\"PeriodicalId\":15566,\"journal\":{\"name\":\"Journal of Drugs in Dermatology\",\"volume\":\"23 12\",\"pages\":\"1108-1113\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Drugs in Dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.36849/jdd.8236\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drugs in Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36849/jdd.8236","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
Pharmacological Complications in Ocular Dermatology: A Review and Update.
Many dermatologic medications have the potential to induce ocular complications. Traditional medications, including corticosteroids, retinoids, antibiotics, antihistamines, and immunosuppressants, have been associated with eye dryness, irritation, allergy, infection, atrophy, pigmentary changes, increased intraocular pressure, and impaired vision. Novel therapeutic agents such as biologics raise new concerns for ocular surface disease and conjunctivitis. Dermatologists should recognize these oculocutaneous side effects for appropriate decision-making, coordinating interdisciplinary care, and optimizing patient outcomes. J Drugs Dermatol. 2024;23(12):1108-1113. doi:10.36849/JDD.8236.
期刊介绍:
The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology.
We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality.
Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.